Catyalyst Pharma (CPRX) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.40 +0.06%
EPS Growth %: -30.9%
Financial Fact:
Loss per share - basic and diluted: -0.05
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -30.9%
Financial Fact:
Loss per share - basic and diluted: -0.05
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
- William Blair Upgrades Backblaze Inc (BLZE) to Market Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
